HOME | NEWSROOM | CONTACT US | SEARCH
 
Cellectar | Company
Cellectar | The Science
Cellectar | Clinical Trials
Cellectar | Development & Manufacturing

Welcome

Capitalizing on the unique characteristics of malignant cancer cells, Cellectar's molecules are designed to "find, treat and follow"™ malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way.
LEARN MORE


News Update

Cellectar, Inc. Begins GMP Production
Radiopharmaceutical production facility to support clinical development for lead drug candidate and other molecules.


Cellectar Raises $13 Million in Private Offering
Cellectar announces completion of a $13 million private offering for phase 1 clinical trial and continuing operations.


Cellectar Opens Custom-Designed Radiopharmaceutical Manufacturing Facility for Novel Cancer Therapeutics
Cellectar announces the opening of a new, custom-designed radiopharmaceutical manufacturing facility in Madison, Wisconsin.


Cellectar Expands Clinical Management Team
Cellectar announces the appointment of Ernest Allen as Director, Clinical Operations and LisaAnn Trembath as Manager, Medical Affairs.


 

©Cellectar, LLC | All Rights Reserved | info@cellectar.com | Site Credit
 
Search Button